유유제약1우

000225KOSPIView the 제약 sectorTheme Bio & healthcare

3,615KRWMarket close of 10/21 (Wed)

Up +0.98%+35KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)3,525KRWDown -2.49%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open: 3,560
High: 3,615
Low: 3,415
Day range: Day range low 3,415 high 3,615, open 3,560, close 3,615, previous close 3,580
Volume: 4×10K shares
: 138.57 million KRW 5.62× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

13% of the way up from the lowest close in 1 year (252 sessions) · -31.1% from the high

Something to check

1 to check: more trading value than usual

Free · no sign-inSource from 2021-05-17

Points to check

Trading valueto check5.6×138.57 million KRW, 5.6× the 20-session average
5.62× the 20-session average · check threshold 3×
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

Daily move+0.98%usual range
EarningsOperating income, 8 quartersOperating income, 8 quarters
Data date10/21 (Wed)Market close

See the full check report

Key figures

: 8.2B KRW
: Not computed for preferred shares
: Not computed for preferred shares
: 2,266,930 shares
Trading value ratio: 5.62× the 20-session average5.6×

52-week closing rangeNow 3,615

3,3755,250

As of 2026-10-21 · KRX

Something to check

1 to check: more trading value than usual

Trading valueto check5.62× the 20-session average5.6×
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Daily moveusual range+0.98% on the reference date, placed against the usual ±0.89% band1.1×
Earningsusual rangeQuarterly operating income bars (6); the four dark bars make up the sum11.4B KRW
Data dateusual rangeMarket close data of 2026-10-21

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected

Revenue35.5B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+8.0%
vs. prior quarter
+3.5%
Operating income4.3B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+9.9%
vs. prior quarter
Turned profitable
Operating margin12.1%Operating margin bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+0.2 pp
vs. prior quarter
+12.5 pp

Quarterly operating income trend

2021Q1 456.44 million KRW2026Q1 4.3B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock	20D	Change	Trading value
삼성바이오로직스	Close over the last 20 sessions +1.5%	Up +1.87%	166.1B KRW
셀트리온	Close over the last 20 sessions +9.6%	Up +0.10%	119.2B KRW
지투지바이오	Close over the last 20 sessions +27.6%	Up +13.78%	49.8B KRW
삼익제약	Close over the last 20 sessions -20.3%	Up +2.58%	47.2B KRW
유한양행	Close over the last 20 sessions +11.7%	Up +0.46%	35.3B KRW

Other share classes of this company · 유유제약 유유제약2우B

Schedule

Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.